Invesco Ltd. Clearside Biomedical, Inc. Transaction History

Invesco Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.72 - $5.72 $753,877 - $1.59 Million	-277,161 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.83 - $7.2 $1.34 Million - $2 Million	277,161 New	277,161 $1.66 Million
Q1 2019 May 15, 2019	SELL	$1.1 - $1.74 $11,764 - $18,609	-10,695 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.0 - $6.12 $10,695 - $65,453	10,695 New	10,695 $11,000

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.